Sensei biotherapeutics to participate in upcoming investor conferences

Boston, aug. 23, 2022 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer, today announced that company management will participate in the following investor conferences in september 2022:
SNSE Ratings Summary
SNSE Quant Ranking